Stifel lowered the firm’s price target on Avanos (AVNS) to $20 from $24 and keeps a Hold rating on the shares after the company announced the retirement of CEO Joe Woody and the appointment of Michael Greiner as interim CEO, along with Q3 results. Despite the overall disappointing top-line performance, Avanos basically held Q3 operating, pre-tax, and net income dollars roughly in line with the firm’s projections, the analyst tells investors in a research note. The firm noted that, despite the nearly $5M revenue shortfall compared to projections and resulting gross margin pressure, Avanos managed to maintain Q3 net income roughly in-line with its thinking. Stifel also said that it’s inclined to view the CEO transition as a positive one.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AVNS:
- Avanos Medical Announces CEO Retirement and Interim Appointment
- Avanos narrows FY24 EPS view to $1.30-$1.35 from $1.30-$1.45
- Avanos reports Q3 adjusted EPS 36c, consensus 35c
- Avanos announces retirement of CEO Joe Woody, Michael Greiner named interim CEO
- AVNS Earnings this Week: How Will it Perform?
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
